BSEInsider Trading / SAST12 Aug 2026 · 12 Aug 2026, 04:10 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhananjay Barot
Senores Pharmaceuticals Ltd · 544319
✦ AI SummaryRegulatory
Senores Pharmaceuticals Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhananjay Barot, indicating a potential substantial acquisition of shares.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011